Mitochondrial respiration in human viable platelets-Methodology and influence of gender, age and storage

Mitochondrion

Volumn 13, Issue 1, 2013, Pages 7-14

  Sjövall, Fredrik ^a,b   Ehinger, Johannes K H ^a   Marelsson, Sigurdur E ^a,c   Morota, Saori ^a   Åsander Frostner, Eleonor ^a   Uchino, Hiroyuki ^d   Lundgren, Johan ^c   Arnbjörnsson, Einar ^c   Hansson, Magnus J ^a,c   Fellman, Vineta ^c,e   Elmér, Eskil ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b Rigshospitalet   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

High resolution respirometry; Human; Mitochondria; Mitochondrial disorders; OXPHOS; Platelets

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; METHODOLOGY; MITOCHONDRIAL RESPIRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIROMETRY; SAMPLE SIZE; SCHOOL CHILD; SEX DIFFERENCE; THROMBOCYTE; THROMBOCYTE PRESERVATION;

ADULT; AGE FACTORS; AGED; BLOOD PLATELETS; CELL RESPIRATION; CHILD; CHILD, PRESCHOOL; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MITOCHONDRIA; SEX FACTORS; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84873304542     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.11.001     Document Type: Article

References (41)

1. Baumgärtl H., Lübbers D. Microaxial needle sensor for polarographic measurement of local O2 pressure in the cellular range of living tissue. Its construction and properties. Polarographic Oxygen Sensors 1983, 37-65. Springer, Berlin, Heidelberg, New York. E. Gnaiger, H. Forstner (Eds.).
2. Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum. Biol. 1992, 64:791-805.
3. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007, 50:790-796.
4. Brand M.D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 2000, 35:811-820.
5. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem. J. 2011, 435:297-312.
6. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
7. Cesar J., DiMinno G., Alam I., Silver M., Murphy S. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 1987, 27:434-437.
8. Cha S.H., Fukushima A., Sakuma K., Kagawa Y. Chronic docosahexaenoic acid intake enhances expression of the gene for uncoupling protein 3 and affects pleiotropic mRNA levels in skeletal muscle of aged C57BL/6NJcl mice. J. Nutr. 2001, 131:2636-2642.
9. Cocco T., Sgobbo P., Clemente M., Lopriore B., Grattagliano I., Di Paola M., Villani G. Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic. Biol. Med. 2005, 38:796-805.
10. Darnold J.R., Vorbeck M.L., Martin A.P. Effect of aging on the oxidative phosphorylation pathway. Mech. Ageing Dev. 1990, 53:157-167.
11. Davis L.M., Rho J.M., Sullivan P.G. UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia 2008, 49(Suppl. 8):117-119.
12. Ferreira I.L., Resende R., Ferreiro E., Rego A.C., Pereira C.F. Multiple defects in energy metabolism in Alzheimer's disease. Curr. Drug Targets 2010, 11:1193-1206.
13. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int. J. Biochem. Cell Biol. 2009, 41:1837-1845.
14. Gnaiger E., Kuznetsov A.V., Lassnig B., Fuchs A., Reck M. High-resolution respirometry - optimum permeabilization of the cell membrane by digitonin. BioThermoKinetics in the Post Genomic Era 1998, 85-95. Chalmers Reproservice, Göteborg. C. Larsson, I.L. Påhlman, L. Gustafsson (Eds.).
15. Gnaiger E., Kuznetsov A.V., Schneeberger S., Seiler R., Brandacher G., Steurer W., Margreiter R. Mitochondria in the cold. Life in the Cold 2000, 431-442. Springer, Heidelberg, Berlin, New York. G. Heldmaier, M. Klingenspor (Eds.).
16. Haas R.H., Parikh S., Falk M.J., Saneto R.P., Wolf N.I., Darin N., Wong L.J., Cohen B.H., Naviaux R.K. The in-depth evaluation of suspected mitochondrial disease. Mol. Genet. Metab. 2008, 94:16-37.
17. Hauptmann S., Keil U., Scherping I., Bonert A., Eckert A., Muller W.E. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease. Exp. Gerontol. 2006, 41:668-673.
18. Hutter E., Unterluggauer H., Garedew A., Jansen-Durr P., Gnaiger E. High-resolution respirometry-a modern tool in aging research. Exp. Gerontol. 2006, 41:103-109.
19. Johannsen D.L., Ravussin E. Obesity in the elderly: is faulty metabolism to blame?. Aging Health 2010, 6:159-167.
20. Kilkson H., Holme S., Murphy S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984, 64:406-414.
21. Kitchens C.S., Newcomb T.F. Human platelet respiration. J. Appl. Physiol. 1968, 25:581-585.
22. Kones R. Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition. Nutr. Clin. Pract. 2010, 25:371-389.
23. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., Schapira A.H. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 1992, 32:782-788.
24. Kuznetsov A.V., Strobl D., Ruttmann E., Konigsrainer A., Margreiter R., Gnaiger E. Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal. Biochem. 2002, 305:186-194.
25. Lemieux H., Semsroth S., Antretter H., Hofer D., Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int. J. Biochem. Cell Biol. 2011, 43:1729-1738.
26. Lenaz G., Genova M.L. Structural and functional organization of the mitochondrial respiratory chain: a dynamic super-assembly. Int. J. Biochem. Cell Biol. 2009, 41:1750-1772.
27. Lesnefsky E.J., Hoppel C.L. Oxidative phosphorylation and aging. Ageing Res. Rev. 2006, 5:402-433.
28. Merlo Pich M., Bovina C., Formiggini G., Cometti G.G., Ghelli A., Parenti Castelli G., Genova M.L., Marchetti M., Semeraro S., Lenaz G. Inhibitor sensitivity of respiratory complex I in human platelets: a possible biomarker of ageing. FEBS Lett. 1996, 380:176-178.
29. Nicholls D.G. The effective proton conductance of the inner membrane of mitochondria from brown adipose tissue. Dependency on proton electrochemical potential gradient. Eur. J. Biochem. 1977, 77:349-356.
30. Nulton-Persson A.C., Szweda L.I. Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 2001, 276:23357-23361.
31. Picard M., Taivassalo T., Gouspillou G., Hepple R.T. Mitochondria: isolation, structure and function. J. Physiol. 2011, 589:4413-4421.
32. Rasmussen U.F., Krustrup P., Kjaer M., Rasmussen H.N. Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria. Exp. Gerontol. 2003, 38:877-886.
33. Rasmussen U.F., Krustrup P., Kjaer M., Rasmussen H.N. Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch. 2003, 446:270-278.
34. Rosenstock T.R., Duarte A.I., Rego A.C. Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench. Curr. Drug Targets 2010, 11:1218-1236.
35. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., Letellier T. Mitochondrial threshold effects. Biochem. J. 2003, 370:751-762.
36. Sjövall F., Morota S., Hansson M.J., Friberg H., Gnaiger E., Elmer E. Sepsis induces platelet mitochondrial uncoupling and a gradual increase in respiratory capacity that is negatively associated with clinical outcome. Crit. Care 2010, 14:11.
37. Tonkonogi M., Fernstrom M., Walsh B., Ji L.L., Rooyackers O., Hammarqvist F., Wernerman J., Sahlin K. Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflugers Arch. 2003, 446:261-269.
38. Vendelbo M.H., Nair K.S. Mitochondrial longevity pathways. Biochim. Biophys. Acta 2011, 1813:634-644.
39. Xu J., Shi C., Li Q., Wu J., Forster E.L., Yew D.T. Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. J. Bioenerg. Biomembr. 2007, 39:195-202.
40. Yamori Y. Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers. Exp. Clin. Cardiol. 2006, 11:94-98.
41. Yanicostas C., Soussi-Yanicostas N., El-Khoury R., Benit P., Rustin P. Developmental aspects of respiratory chain from fetus to infancy. Semin. Fetal Neonatal Med. 2011, 16:175-180.